Cytotoxic T-lymphocyte associated antigen 4 polymorphisms and asthma risk: a meta-analysis

PLoS One. 2012;7(7):e42062. doi: 10.1371/journal.pone.0042062. Epub 2012 Jul 26.

Abstract

Background: A number of studies assessed the association of cytotoxic T-lymphocyte associated antigen 4 (CTLA-4) gene polymorphisms with asthma in different populations. However, the results were contradictory. We performed a meta-analysis to examine the association between CTLA-4 polymorphisms and asthma susceptibility.

Methods: Pubmed, EMBASE, HuGE Navigator, and Wanfang Database were searched. Data were extracted independently by two reviewers. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of associations.

Results: Seventeen studies involving 6378 cases and 8674 controls were included. Significant association between +49 A/G polymorphism and asthma was observed for AA vs. AG+GG (OR = 1.18, 95% CI 1.01-1.37, P = 0.04). There were no significant associations between -318 C/T, -1147 C/T, CT60 A/G, -1722 C/T, or rs926169 polymorphisms and asthma risk.

Conclusions: This meta-analysis suggested that the +49 A/G polymorphism in CTLA-4 was a risk factor for asthma.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Asthma / genetics*
  • CTLA-4 Antigen / genetics*
  • Child
  • Genetic Predisposition to Disease / genetics*
  • Humans
  • Polymorphism, Genetic*

Substances

  • CTLA-4 Antigen

Grants and funding

This study was supported by grants NO. 81170025 from National Natural Science Foundation of China and projects of “Major New Drugs Innovation and Development” from the National Ministry of Science and Technology (NO. 2011ZX09302-003-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.